AI assistant
Sending…
VOLITIONRX LTD — Director's Dealing 2016
May 24, 2016
34395_dirs_2016-05-24_47fd37b8-c849-4ffb-b75a-c164d530aff0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2016-05-20
Reporting Person: Skaff Habib (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-05-20 | Common Stock | M | 4000 | $3 | Acquired | 18580 | Direct |
| 2016-05-20 | Common Stock | F | 3390 | $3.54 | Disposed | 15190 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-05-20 | Stock Option (Right to Buy) | $3 | M | 4000 | Disposed | 2016-05-25 | Common Stock (4000) | Direct |
Footnotes
F1: Represents the aggregate amount of shares of VolitionRx Limited Common Stock disposed of in a cashless exercise.
More from VOLITIONRX LTD
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 13
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 23
Regulatory Filings
2026
Apr 17
Regulatory Filings
2026
Apr 1